Healthcare

Algorae Pharma Advances Drug Development with AlgoraeOS

Highlights,Algorae,Pharmaceuticals,identifies,24 new drug targets using AI,.,Preclinical studies to assess targets for oncology treatments,.,Expansion...

Knosys Secures Two-Year Contract Extension with Healthdirect

Highlights,Knosys extends SaaS contract with,Healthdirect,until 2027,.,KnowledgeIQ,continues as a core tool in healthcare and beyond,.,Shares of Knosy...

Race Oncology Identifies 39 FTO Inhibitors for Cancer Therapy

Highlights,Race Oncology discovers 39 molecules targeting cancer-linked proteins,.,Focus on FTO inhibition, key in cancer RNA regulation,.,Collaborati...

Race Oncology’s FTO Breakthrough: Pioneering RNA Epigenetics for New...

Highlights,Race Oncology discovers unique FTO inhibitors in RNA epigenetics research,.,Program,identifies,39 molecular candidates with potential for p...

PainChek Targets FDA Approval for Its Adult App Expansion

Highlights,PainChek,has applied for FDA De Novo approval for its Adult App.,US-based validation study completion supports the application.,Partnership...

Singular Health Partners with Miami Clinic for 3D Imaging Breakthrou...

Highlights,Singular Health announces partnership with Miami-based health clinic,.,Focus on advancing its 3Dicom technology through a commercial pilot,...

Biotron Limited Rolls Out New Shares on ASX

Highlights:,Biotron Limited issued 20,751 fully paid ordinary shares on the ASX.,The share issuance results from the exercise of options and conversio...

Sonic Healthcare Ltd (ASX: SHL) Up 4% After AGM Update

Highlights:,Sonic Healthcare (ASX: SHL) shares rise 4% to $27.30 after providing key updates during its AGM.,The company reported $9 billion in FY24 r...

Tryptamine Therapeutics Readies Phase 2 Trials for Psilocin Therapy

Highlights,Tryptamine Therapeutics progresses to Phase 2 clinical trials for TRP-8803,.,TRP-8803,demonstrated,enhanced safety and efficiency in Phase...

CSL Shares Shed 10% in a Month: Market Disruption a Possible Factor

Highlights:,CSL Ltd shares have experienced a 9.77% decline over the past month.,The drop in CSL shares aligns with broader selloffs in the healthcare...

CSL Shares Dip Amid Concerns Over RFK Jr’s Vaccine Policies

Highlights,C,SL falls to a six-month low amid vaccine policy uncertainty,.,Broader ASX healthcare sector declines following the nomination,.,Potential...

Amplia Therapeutics Teams Up with Next&Bio for Preclinical Research...

Highlights,Amplia,Therapeutics partners with,Next&Bio,to evaluate the impact of FAK inhibitors on pancreatic cancer,.,The study explores potential,syn...

Radiopharm Theranostics Boosts Prospects with Pancreatic Cancer Imag...

Highlights,Radiopharm,Theranostics,’ imaging drug RAD 301 shows promising results for pancreatic cancer detection,.,A published study supports its abi...

InhaleRX (ASX:IRX) Gains Phase 2 Approval for Non-Opioid Cancer Pain...

Highlights,InhaleRX,receives approval for Phase 2 trial to explore non-opioid cancer pain therapy.,IRX-211 aims to offer a safe, fast-acting pain reli...

Opthea’s Vision Therapy Gains Significant R&D Funding Boost

Highlights,Opthea,receives significant R&D tax incentive from the Australian Taxation Office,.,Funding supports,sozinibercept,development for wet age-...

Recce Pharmaceuticals (ASX:RCE) Secures $6.75 Million R&D Tax Incent...

Highlights,Recce Pharmaceuticals receives a significant $6.75 million R&D tax rebate.,Funds boost Recce’s development of advanced synthetic anti-infec...

Neuren Pharmaceuticals Shares Surge 8.4% on Announcement of AU$50Mn...

Highlights,Neuren Pharmaceuticals’ shares jumped 8.4% to AU$17.94, marking the highest level since August and making it the top gainer on the ASX 200...

Recce Pharmaceuticals Bolstered by R&D Rebate and Advances in Clinic...

Highlights,Recce Pharmaceuticals received over A$6.75 million as an R&D Tax Incentive rebate.,Funds to support global R&D initiatives, including upcom...

Can BlinkLab’s Tech Revolutionize Autism and ADHD Diagnosis?

Highlights,BlinkLab,collaborates with Monash University on a groundbreaking autism and ADHD study.,The study,utilizes,eye-tracking tech to,identify,un...

Is Paragon Care (ASX:PGC) Enhancing Performance with Smart Financial...

Highlights,Paragon Care’s stock rose by 11% recently, drawing attention to its financial growth.,ROE highlights Paragon Care’s profitability and reinv...